148 results
Page 3 of 8
8-K
e2s0bqhhjhvkww
28 Jun 21
Other Events
6:07am
8-K
EX-99.1
bza7fievforw84lz
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
q1287
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
ith2u5hef1mg
24 May 21
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-99.1
1q3m16sr88jqlhv0h
21 May 21
CORRECTION — EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s
3:38pm
8-K
EX-99.1
on18zjf4mnzdquw1tim
6 May 21
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:24pm
DEFA14A
sqbfmqfdt61hcv
6 Apr 21
Additional proxy soliciting materials
4:07pm
S-8
5bjicfw06bz18i9n5
25 Feb 21
Registration of securities for employees
5:30pm
S-8
EX-23.1
xirp40v6hw c7jl9tf
25 Feb 21
Registration of securities for employees
5:30pm
S-3ASR
EX-4.6
i8r0h049b 651324
10 Nov 20
Automatic shelf registration
5:13pm